High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.

@article{Ketelaars2017HighriskHP,
  title={High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.},
  author={Pleun J. W. Ketelaars and Remko P. Bosgraaf and Albertus G. Siebers and Leon F.A.G. Massuger and Carla A P Wauters and Jeanette C Rahamat-Langendoen and Adriaan J. C. van den Brule and Joanna Inthout and Willem J G Melchers and Ruud L. M. Bekkers},
  journal={Preventive medicine},
  year={2017},
  volume={101},
  pages={
          96-101
        }
}
In 2017 the cervical cancer screening program in The Netherlands will be revised. Cervical smears will primarily be tested for the presence of high-risk human papillomavirus (hrHPV) instead of cytology, and vaginal self-sampling will be offered to non-responders. This includes a potential risk that part of the women who would otherwise opt for a cervical smear will wait for self-sampling. However, self-sampling for hrHPV in a responder population has never been studied yet. The aim of this… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 31 REFERENCES

Methylationmarker analysis andHPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer

V. M. Verhoef, D. A. Heideman, +4 authors A.T
  • Gynecol. Oncol
  • 2014
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…